Chemours Company (The) ($CC) Stock Forecast: Up 5.4% Today

What is Chemours Company (The)?

Chemours (CC) is a diversified chemicals company operating in industrial and specialty chemicals across various markets. The company has been focusing on responsible procurement and sustainability initiatives in its supply chain.

Why is Chemours Company (The) going up?

CC stock is up 5.4% on Apr 10, 2026 15:55

• Chemours (CC) experienced a strong bullish movement today due to an increased target price and maintained Buy rating by a leading financial institution. This positive outlook reflects confidence in the company's growth potential.
• The high-performance fluoropolymers (HPF) market is projected to grow, potentially benefiting Chemours given its presence in industrial chemicals, including components for aerospace and automotive industries.
• Despite the positive forecast and price target increase, Chemours reported a negative net margin and a year-over-year revenue decline, suggesting possible challenges ahead despite the bullish market movement.
• Ongoing discussions by the EU chemicals agency regarding PFAS chemicals could have implications for Chemours in the future, underscoring regulatory risks in the industry.

CC Price Chart

CC Technical Analysis

CC News

HPF Market Forecast by Type, Form, Application, End-Use

The high-performance fluoropolymers (HPF) market is projected to grow from USD 4.87 billion in 2025 to USD 6.87 billion by 2030, at a CAGR of 7.1%. This growth is driven by demand for components in aerospace and automotive industries, expansion of PFA/MFA types for electronics, and the thriving use of fine powder forms in coatings. South America is identified as a rapidly growing regional market due to industrialization and increased automotive, oil, and gas operations.

https://www.globenewswire.com/news-release/2026/04/10/3271595/28124/en/HPF-Market-Forecast-by-Type-Form-Application-End-Use-Industry-and-Region-to-2030-Daikin-Industries-AGC-and-Chemours-Co-Lead-the-Industry-Growing-by-2-Billion-Through-2030.html

UBS Raises Target Price for Chemours (CC) to $29, Maintains Buy Rating | CC Stock News

UBS has reaffirmed its Buy rating for Chemours (CC) and increased its target price from $23 to $29, indicating a 26.09% rise and reflecting confidence in the company's growth potential. This update follows several recent analyst adjustments for Chemours, which operates in industrial and specialty chemicals across various markets. Despite the positive UBS rating, the average analyst target price for Chemours is $20.13, suggesting a potential downside from its current price, while GuruFocus estimates a GF Value of $21.59.

https://www.gurufocus.com/news/8785924/ubs-raises-target-price-for-chemours-cc-to-29-maintains-buy-rating-cc-stock-news

UBS Group Issues Positive Forecast for Chemours (NYSE:CC) Stock Price

UBS Group has raised its price target for Chemours (NYSE:CC) to $29 from $23, maintaining a "buy" rating and suggesting a potential upside of approximately 32.7%. Despite this positive outlook, the broader analyst consensus for Chemours remains "Hold" with an average price target of $19.60. The company recently surpassed quarterly earnings estimates but reported a negative net margin and a year-over-year revenue decline.

https://www.marketbeat.com/instant-alerts/ubs-group-issues-positive-forecast-for-chemours-nysecc-stock-price-2026-04-09/

Chemours’ Approach to Responsible Procurement

Chemours outlines its responsible procurement strategy, aiming to embed sustainability across its supply chain by partnering with suppliers who align with its values on safety, human rights, and environmental stewardship. The company uses EcoVadis assessments to measure supplier performance and has significantly exceeded its 2024 goal for supplier sustainability improvement. Chemours is also collaborating with suppliers to collect product carbon footprint data to reduce its Scope 3 emissions.

https://csrwire.com/press-release/chemours-approach-responsible-procurement/

UBS Adjusts Price Target on Chemours to $29 From $23, Maintains Buy Rating

UBS has increased its price target for Chemours (CC) to $29 from $23, while reiterating a Buy rating on the stock. The diversified chemicals company announced a price of $21.84 USD as of its last close. This adjustment comes amidst recent news regarding Chemours' financial activities and ongoing discussions by the EU chemicals agency concerning PFAS chemicals.

https://www.marketscreener.com/news/ubs-adjusts-price-target-on-chemours-to-29-from-23-maintains-buy-rating-ce7e50d8d889f624

Trending Today

Heating Oil ($HEATOIL) Commodity Forecast: Down 5.1% Today

Amylyx Pharmaceuticals ($AMLX) Stock Forecast: Down 5.1% Today

Check Point Software Technologies Ltd. ($CHKP) Stock Forecast: Down 5.2% Today

Palo Alto Networks Inc. ($PANW) Stock Forecast: Down 5.9% Today

TripAdvisor Inc. ($TRIP) Stock Forecast: Down 5.3% Today

Novavax Inc. ($NVAX) Stock Forecast: Down 5.2% Today

Natera, Inc. ($NTRA) Stock Forecast: Down 7.8% Today

ServiceNow Inc. ($NOW) Stock Forecast: Down 7.4% Today

Jetblue Airways Corporation ($JBLU) Stock Forecast: Down 5.1% Today

Akamai Technologies Inc. ($AKAM) Stock Forecast: Down 17.4% Today

Chemours Company (The) Price History

10.03.2026 - CC Stock was up 5.4%

• Chemours (CC) experienced a strong bullish movement today due to an increased target price and maintained Buy rating by a leading financial institution. This positive outlook reflects confidence in the company's growth potential.
• The high-performance fluoropolymers (HPF) market is projected to grow, potentially benefiting Chemours given its presence in industrial chemicals, including components for aerospace and automotive industries.
• Despite the positive forecast and price target increase, Chemours reported a negative net margin and a year-over-year revenue decline, suggesting possible challenges ahead despite the bullish market movement.
• Ongoing discussions by the EU chemicals agency regarding PFAS chemicals could have implications for Chemours in the future, underscoring regulatory risks in the industry.

30.02.2026 - CC Stock was down 5.1%

• Despite a recent 5-day winning streak and reaching a new 52-week high, Chemours stock showed strong bearish movement today.
• Investor profit-taking following the stock's surge in the past few days could explain the bearish pullback.
• Concerns from analysts regarding the company's weak operational performance, financial state, and high valuation might have influenced the bearish sentiment.
• The absence of specific positive developments today likely prompted investors to reassess their positions, resulting in the bearish market trend.

20.02.2026 - CC Stock was down 5.0%

• Today's downward trend in CC's stock price could be linked to an investigation initiated by the Portnoy Law Firm into potential securities fraud, triggered by disappointing financial results in Q4 and full-year 2025. This development possibly eroded investor confidence, resulting in the stock decline.
• The Brunswick County Board of Commissioners' unanimous disapproval of Chemours' proposed expansion due to worries about PFAS contamination in the Cape Fear River watershed might have exacerbated negative investor sentiment, contributing to the bearish movement.
• Despite the adverse updates, the recent intraday stock price increase of 7.65% and a subsequent 9.4% rise following analysts' heightened price targets indicate some positive market sentiment. Nevertheless, enduring challenges like a high debt-to-equity ratio and negative return on equity are persisting factors impacting the stock's performance.

08.03.2026 - CC Stock was down 5.8%

• The bearish movement in CC's stock today could be attributed to concerns surrounding the ongoing lawsuit with the Cape Fear Public Utility Authority over PFAS contamination in drinking water.
• Despite a company raising its price target on CC and maintaining an "Outperform" rating, the market may be reacting to uncertainties regarding the impact of ultrashort-chain PFAS compounds on the company's operations.
• The upsizing and pricing of the $700 million senior notes offering by Chemours could have also influenced the bearish sentiment, as investors may be wary of the company's increased debt burden.
• The significant increase in stake by SG Americas Securities LLC signals long-term confidence in Chemours, but the market may be focusing more on the immediate challenges the company is facing with regards to environmental issues and financial decisions.

19.02.2026 - CC Stock was down 5.6%

• Today's significant bearish movement in CC's stock might be related to investors having a negative reaction towards the company's cautious capital allocation approach. This was highlighted by a debt refinance with higher coupon rates, an increase in CEO pay, and a dividend cut.
• Concerns have been raised among investors due to long-term challenges like a high debt-to-equity ratio and negative return on equity, which could have led to the stock sell-off.
• Although there has been positive short-term performance and an earnings beat as of late, investor sentiment may be impacted by ongoing PFAS liabilities and market risks, ultimately contributing to today's bearish market movement.

26.02.2026 - CC Stock was up 5.1%

• Chemours' stock price surged by 10.11% following the completion of a successful debt swap, indicating investor confidence in the company's financial stability and growth prospects.
• The strategic agreement with SRF Limited to boost the supply of key low GWP products highlights Chemours' commitment to sustainability and meeting market demand, which likely contributed to the positive market sentiment.
• Despite facing challenges such as high debt levels and legal battles, Chemours' focus on next-generation refrigerants and environmental regulations positions it well for future growth in the chemical industry.
• The company's engagement in STEM education initiatives showcases its dedication to fostering talent and innovation, creating a positive image that resonates with investors and stakeholders.

09.03.2026 - CC Stock was up 5.6%

• CC reached a 52-week high at $22.56, marking a 139% increase in the past year, potentially attracting positivity from investors.
• Mizuho raised CC's price target to $25 from $21, upholding an "Outperform" rating, potentially enhancing investor confidence and influencing the bullish trend.
• Despite the lawsuit and regulatory challenges, CC's optimistic earnings forecast for 2026 and expected improvements in titanium dioxide EBITDA margins may have outweighed these issues, propelling the stock.
• The options chain analysis, detailing call and put options expiring in May 2026, possibly signified a bullish outlook among traders, adding momentum to CC's stock.

17.02.2026 - CC Stock was up 7.5%

• Reasons for the recent strong stock performance of Chemours include:
• Reduction of 77.6% in Cinctive Capital Management LP's stake, signaling a shift in positions.
• Successful completion of a $700 million private offering of senior unsecured notes due 2034, bolstering investor trust in the company's financial structure.
• Despite worries about PFAS liabilities and market risks, the company exceeded Q3 earnings expectations with $1.33 billion in revenue and maintained a quarterly dividend, painting a positive picture for investors.
• Discordant fair value assessments and differing opinions on the company's actual value may have led to stock price volatility, prompting today's upward movement as investors reevaluate their positions in light of the latest developments.

25.02.2026 - CC Stock was up 5.1%

• A successful $700 million debt refinancing and insider buying activities have eased financial concerns, fostering a favorable investor sentiment.
• Price target upgrades from various firms, including UBS and Mizuho, have been influenced by robust quarterly earnings within the specialized solutions segment, contributing to the uptrend in the stock.
• Despite potential challenges like regulatory scrutiny regarding environmental issues such as PFAS liabilities, Chemours' strategic outlook remains promising due to continuous innovation efforts and substantial order backlogs.
• An investigation by The Portnoy Law Firm subsequent to disappointing Q4 and full-year 2025 financial results may have initially dampened investor confidence; however, positive developments thereafter appear to have reversed the stock's trajectory.

24.02.2026 - CC Stock was up 6.1%

• The bullish movement in CC's stock can be attributed to the successful $700 million private sale of senior notes and insider buying, which helped alleviate financial concerns and boost investor confidence.
• Analyst upgrades and positive outlook on the company's strategic direction, particularly in the thermal and specialized solutions segment, have also contributed to the stock surge.
• Despite ongoing legal challenges and environmental controversies, including the lawsuit against DuPont and Chemours and opposition to the Fayetteville expansion, the market seems to be focusing more on the company-specific improvements and growth prospects, leading to the bullish momentum in CC's stock.

23.02.2026 - CC Stock was up 5.0%

• The North Carolina Supreme Court reviewing a lawsuit against DuPont and Chemours may have introduced legal uncertainties and risks for the company, impacting market sentiment initially.
• An investigation into potential securities fraud by the Portnoy Law Firm following disappointing financial results likely contributed to CC's stock price decline.
• The subsequent increase in CC's stock price may be linked to three analyst firms raising their price targets for the company, indicating improved sentiment and potentially attracting more institutional investors.
• The strong intraday surge and outperformance of the S&P 500 suggest a positive short-term market response to the raised price targets and overall analyst enthusiasm, despite CC's enduring financial challenges and environmental issues.

01.03.2026 - CC Stock was down 5.0%

• The bearish movement in Chemours stock today could be attributed to profit-taking by investors after the recent 5-day winning spree, where the stock climbed 22%.
• Concerns may have arisen among investors about potential legal liabilities and future financial impacts on the company due to the news about a potential new lawsuit against Chemours for PFAS contamination in North Carolina.
• Despite the positive collaboration with the University of Kansas on sustainable cooling technologies, the overall sentiment from analysts describing the stock as "Very Unattractive" due to weak operating performance and high valuation could have also influenced today's bearish market movement.